Patent · US Expired

Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures

US5578571A · kind A · utility

5Cited by

1References

5Claims

0Family size

Assignee

Symbiotec Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie mbH · DE

Inventors

Michael Zeppezauer · Scheidt, DE
Hans-Peter Leinenbach · Eisenlohrsweg, AT

Key dates

Filing date	Sep 22, 1994
Grant date	Nov 26, 1996
Priority date	—
Expiry date	Sep 22, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

According to this invention the combination of active substances for use in therapeutic procedures consists of at least one cytostatic compound, e.g. vincristine, methotrexate, cisplatin as the first agent and at least one histone and/or one active histone fragment with cytostatic or cytotoxic activity as the second agent. Both active agents act synergistically at the site of the pathogenic process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.